List of Alteogen patents

List of Alteogen patents

List of Sabre Corporation patents

List of Rapt Industries patents

List of University of Hull patents

List of funds, trusts, and other financial vehicles patents

List of companies in Unseen Capital's investment portfolio

Patents where

Current Assignee

Name

is

Alteogen

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9814782 Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for same	Patent 9814782 was granted and assigned to Alteogen on November, 2017 by the United States Patent and Trademark Office.	Alteogen	Alteogen		United States Patent and Trademark Office	9814782	November 14, 2017
	‌ US Patent 9982032 Stable liquid formulation of fusion protein with IgG Fc domain	Patent 9982032 was granted and assigned to Alteogen on May, 2018 by the United States Patent and Trademark Office.	Alteogen	Alteogen		United States Patent and Trademark Office	9982032	May 29, 2018
	‌ US Patent 11414476 Method for producing fusion protein having IgG Fc domain	Patent 11414476 was granted and assigned to Alteogen on August, 2022 by the United States Patent and Trademark Office.	Alteogen	Alteogen		United States Patent and Trademark Office	11414476	August 16, 2022
	‌ US Patent 11235065 Antibody-drug conjugate comprising modified antibody	Patent 11235065 was granted and assigned to Alteogen on February, 2022 by the United States Patent and Trademark Office.	Alteogen	Alteogen		United States Patent and Trademark Office	11235065	February 1, 2022
	‌ US Patent 9821059 Composition for stabilizing protein and pharmaceutical formulation comprising the same	Patent 9821059 was granted and assigned to Alteogen on November, 2017 by the United States Patent and Trademark Office.	Alteogen	Alteogen		United States Patent and Trademark Office	9821059	November 21, 2017
	‌ US Patent 9012606 In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasng in vivo half-life using same	Patent 9012606 was granted and assigned to Alteogen on April, 2015 by the United States Patent and Trademark Office.		Alteogen		United States Patent and Trademark Office	9012606	April 21, 2015
	‌ US Patent 9474803 Composition for stabilizing fusion protein in which protein and FC domain are fused	Patent 9474803 was granted and assigned to Alteogen on October, 2016 by the United States Patent and Trademark Office.	Alteogen	Alteogen		United States Patent and Trademark Office	9474803	October 25, 2016
	‌ US Patent 9051395 Alpha-1 antitrypsin variant, preparation method thereof and use thereof	Patent 9051395 was granted and assigned to Alteogen on June, 2015 by the United States Patent and Trademark Office.		Alteogen		United States Patent and Trademark Office	9051395	June 9, 2015
	‌ US Patent 12090210 Antibody-drug conjugate comprising modified antibody	Patent 12090210 was granted and assigned to Alteogen on September, 2024 by the United States Patent and Trademark Office.	Alteogen	Alteogen		United States Patent and Trademark Office	12090210	September 17, 2024
	‌ US Patent 11981719 Growth hormone receptor antagonists and fusion proteins thereof	Patent 11981719 was granted and assigned to Alteogen on May, 2024 by the United States Patent and Trademark Office.	Alteogen	Alteogen		United States Patent and Trademark Office	11981719	May 14, 2024
	‌ US Patent 11866492 Antibody specifically binding to FOLR1 and uses thereof	Patent 11866492 was granted and assigned to Alteogen on January, 2024 by the United States Patent and Trademark Office.	Alteogen	Alteogen		United States Patent and Trademark Office	11866492	January 9, 2024

11 results

0 selected

11 results

0 selected